Yokohama, Japan

Akiko Ohara

This inventor holds 1 USPTO granted patent. Top assignee: Mitsubishi Chemical Corporation. Active years: 1999.


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 103(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Akiko Ohara: Innovator in Microbial Biotechnology

Introduction

Akiko Ohara is a prominent inventor based in Yokohama, Japan. She has made significant contributions to the field of microbial biotechnology, particularly in the production of esters through innovative methods. Her work has implications for various applications in the chemical and pharmaceutical industries.

Latest Patents

Akiko Ohara holds a patent for a method that involves the production of esters using microbial cells. The patent describes a process where a microorganism acts on the ester of γ-halogenated-acetoacetic acid. This method allows for the stereospecific reduction of the carbonyl group at the β-position, resulting in the production of the ester of (S)-γ-halogenated-β-hydroxybutyric acid. This process is notable for its efficiency, achieving high yields in a short period of time.

Career Highlights

Ohara is currently associated with Mitsubishi Chemical Corporation, where she continues to advance her research in microbial applications. Her innovative approach has garnered attention in the scientific community, and she is recognized for her expertise in the field.

Collaborations

Throughout her career, Akiko has collaborated with notable colleagues, including Masahiro Yamagishi and Yukie Takai. These collaborations have further enriched her research and contributed to the development of her patented methods.

Conclusion

Akiko Ohara's work exemplifies the intersection of innovation and biotechnology. Her contributions to the field through her patented methods highlight the potential of microbial processes in producing valuable chemical compounds.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…